跳至主要内容
临床试验/TCTR20220906002
TCTR20220906002尚未招募1 期

Efficacy and safety of Xuefu Zhuyu Granules combined with Western medicine in the treatment of angina pectoris of coronary heart disease: A study protocol of a randomized, double-blind, placebo-controlled clinical trial

Dong Liu0 个研究点目标入组 52 人开始时间: 2022年9月6日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • (1) Meet the diagnostic criteria of coronary heart disease angina pectoris in traditional Chinese medicine and Western medicine, coronary angiography or coronary angiography showed at least one coronary artery stenosis and catheter stenosis at least 50%;
  • (2) Aged at least 18 years old, and at least 70 years old;
  • (3) Canadian Cardiovascular Society (CCS) classification of angina pectoris is grade I-III;
  • (4) Angina pectoris attack frequency at least 2 times/week, and less than or equal to 6 times/day;
  • (5) Patients agreed to join this study, and signed informed consent.

排除标准

  • (1) Patients who have undergone coronary artery bypass surgery;
  • (2) Patients with other serious diseases (such as severe cardiopulmonary dysfunction, tumor, etc.) or ALT, AST or Cr reaching 1.5 times of the normal upper limit
  • (3) Patients with other diseases that may increase the risk of bleeding (such as cerebral hemorrhage, upper gastrointestinal bleeding), the platelet count decreased, coagulation dysfunction, etc.
  • (4) Pregnant, preparing for pregnancy or lactating women;
  • (5) Patients are allergic to the use of drugs in the study;
  • (6) Participated in or are participating in other clinical trials in the past 1 month.

研究者

发起方
Dong Liu

相似试验

Efficacy and safety of Xuefu Zhuyu Granules combined... | 临床试验